Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Caplin Point Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 398.40 -3.65  | -0.91% -5.94% 15.89 3,009.45
NSE Price: Oct 15, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:59 398.40 -3.65 -0.91% 402.05 402.05 13,353 395.00 - 403.30
BSE Oct 15, 2019 397.85 -2.15 -0.54% 399.75 400.00 1,214 396.35 - 403.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 39,347 P/B: 4.45 NSE Code: CAPLIPOINT
52-Week Range: R 296.05 - 489.75 Dividend Yield: 0.55% BSE Code: 524742
TTM EPS: R 25.04 Book Value: R 89.38 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Caplin Point Laboratories 4.19 -8.77 -5.66 -6.20 11.79 39.51 -
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of BSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 20.16 39.55 -
Net Profit 22.07 56.83 -
EPS 21.90 56.78 -
Book Value 73.58 72.06 -
Average
Operating Margin 38.68 36.92 31.19
Net Margin 26.44 25.27 20.92
Return on Networth 35.79 46.73 48.72
Return on Investment 45.59 59.57 62.37
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 2.78 31.47 2.78
Operating Profit 6.56 31.50 6.56
Net Profit 0.43 33.90 0.43
EPS 0.84 34.14 0.84
TTM
Revenue 7.11 23.45 7.11
Operating Profit 6.87 26.03 6.87
Net Profit 7.18 29.87 7.18
EPS 7.24 29.76 7.24
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Caplin Point Laboratories 3,009.45 694.78 189.23 26.40 35.79 4.45 15.89
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Feb 11, 2019 Sridhar Ganesan  Buy ESOP 26,750 350.70 93.81
Aug 10, 2018 Matthews India Fund  Buy Market 92,607 398.65 369.18
Jun 06, 2018 C C Paarthipan  Buy Market 10,427 396.75 41.37
Jun 06, 2018 C C Paarthipan  Buy Open Market 10,427 396.75 41.37
Jun 06, 2018 Dr Sridhar Ganesan  Buy Market 8,000 396.75 31.74
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Motilal Oswal Mutual Fund 0.001 - - - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Caplin Point Laboratories Ltd.

Address: Narbavi, No . 3, Lakshmanan Street, T Nagar, Chennai, Tamil Nadu - 600017 | Phone: 91-044-28156653 / 28156905 | Fax: 91-044-28154952

Email: [email protected]

Website: www.caplinpoint.net

Registrar & Transfer Agent: Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

Address: II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai, II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar | Phone: 044-28140801 | Fax: 044-28142479

Email: [email protected]

Essential checks
Altman Z-Score
20.31
Piotroski F-Score
5
Modified C-Score
3
5-Years Price to Earnings
15.89
5-Years Price to Book
4.45
Earnings Yield
EBIT / Enterprise value
8.69%
PEG
Price / Earnings to growth ratio
0.33
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Dishman Carbogen Amcis R160.80 +0.56%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59